Results

Total Results: 1,528 records

Showing results for "drugs".

21. S96 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
    October 01, 2007 - Of 10,383 reports in 2004, 100% listed patient age, sex, and disposition; 98% listed the implicated drugs … provides detailed and timely infor- mation on outpatient ADEs treated in EDs and identifies specific drugs … Deiden- tified data are then forwarded to CDC where all case reports involving pharmaceutical products … drugs are suspected, this information may be added as a free-text description. … Risk assessment of drugs, biologics and therapeutic devices: present and future issues.

22. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
    March 01, 2013 - Trospium chloride 60 mg once daily Placebo Esprit Pharma and Indevus Pharmaceuticals Inc. … (formerly Indevus Pharmaceuticals Inc.). … Oxybutynin 2.5 mg twice daily Placebo Funded by Smith and Nephew Pharmaceuticals Ltd. … chloride Propantheline and placebo Pharmcia Leo Therapeutics, Helsingborg, Sweden provided the pharmaceutical … preparations used in this study Toglia, 201075 Study: Post-hoc Karram, 200939 VENUS N: 739

23. Disposition of Comments for Migraine in Adults: Preventive Pharmacologic Treatments (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
    April 18, 2013 - We did review off-label drugs available in the US. … of the outcomes with different drugs. … The large number of off label drugs may reflects the fact that approved drugs have undesirable balance … drugs from different classes. … , as well as individual drugs.

24. S5 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
    October 01, 2007 - The advent of Medicare Part D for outpatient prescription drugs has drawn significant attention to the … or outcome misclassification), random er- ror, confounding by clinical conditions, indications for drugs … , both alone and in comparison across drugs. … Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients … Comparison of meta- analytic results of indirect, direct, and combined comparisons of drugs for chronic

25. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the single topic for which (1) preliminary phase III data for drugs (or … Frustratingly, an unusually high percentage of investigational drugs have not met primary endpoints

26. Addressing Knowledge Gaps in Type 2 Diabetes Therapeutics: Comparative Effectiveness and Safety of Oral Antidiabetic Drugs | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/diabetes-oral-drugs-safety-knowledge-gaps/research

27. Ced -Appendix-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
    May 29, 2025 - Drugs and devices that are subject to CED should qualify for Medicare transitional pass-through status … Application of CED to on-label uses of drugs and biologicals restricts patient access. … Caution against the broad use of CED for on-label uses of drugs and biologics that have gone through … Ban CED for drugs with accelerated approval. … Recommends that on-label uses of drugs and biologicals be excluded from CED restrictions.

28. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - When considering categories of these interventions, such as drugs, devices, and procedures, new pharmaceuticals … that new pharmaceuticals/biotechnologies and new off-label uses of existing pharmaceuticals constitute … New Era of High-Cost Pharmaceuticals The proportion of costs attributable to new specialty pharmaceuticals … Although anti-obesity drugs are not part of the high-cost paradigm seen with specialty pharmaceuticals … The demand for new antiobesity drugs has been addressed in large part by three new oral drugs approved

29. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
    August 05, 2010 - Patients with osteoarthritis also use over-the-counter supplements not regulated by the FDA as pharmaceuticals … Pharmacokinetics, Indications, and Dosing of drugs to be included. … Oral drugs (trade names provided only for drugs under patent) Drug (any trade name): acetaminophen … Non-steroidal anti-inflammatory drugs. … Non-steroidal anti-inflammatory drugs for low-back pain.

30. FRN 35 - Preventive Pharmacological Treatments for Migraine in Adults: Future Research Needs (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-future_research.pdf
    April 01, 2013 - Topiramate and propranolol decreased use of drugs for acute migraine attacks. … among approved drugs. … Approved drugs were more effective than off-label drugs except for the angiotensin II receptor blocker … or approved versus off-label drugs. … or approved versus off label drugs.

31. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0024_06-09-2008.pdf
    January 01, 2008 - manic or depressive phases, rapid cycling, mixed states), do the typical and atypical antipsychotic drugs … For adults experiencing a first episode of schizophrenia, do the atypical antipsychotic drugs differ … comparative evidence that differences in adherence or persistence among the atypical antipsychotic drugs … developmental disorders or disruptive behavior disorders, do the typical and atypical antipsychotic drugs … Behavioral and Psychological Symptoms of Dementia (BPSD), do the typical and atypical antipsychotic drugs

32. Dietary Supplements in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/dietary-supplements/research

33. #14 SUBSTANCE ABUSE (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
    January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … However, experts shared the belief that these drugs’ benefits would prove to be only incremental … Prescription drugs: abuse and addiction. [internet].

34. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/dementia_hi_impact.pdf
    January 01, 2012 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … interventions expected to be within 0 to 4 years of potential diffusion (e.g., in phase III trials for pharmaceuticals … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The search is on for ways to definitively diagnose AD and for drugs, biologics, and alternative or

35. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - specific dietary supplements (when compared to cardiovascular drugs alone or cardiovascular drugs and … Classes of commonly used cardiovascular drugs to be considered (excluding drugs used exclusively for … Analytic Framework for Dietary Supplement Use in Adults Taking Cardiovascular Drugs. … Drugs Aging 2009;26(Suppl 1):41-51. 4. Garner JB. … Drugs 2009;69:1777-98. 7. Miller KL, Liebowitz RS, Newby LK.

36. PEPTIC ULCER #11 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - NPS Pharmaceuticals, Inc.. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2014 Jun. 18 p. 8. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 May 12 [accessed 2011 Jul 15]. [2 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 Oct 31 [accessed 2011 Nov 11]. [4 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Dec 21. 45 p. 14.

37. Migraine-Prevention Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
    June 01, 2013 - , pediatricians prescribe drugs approved for adults or off- label drugs (approved for clinical conditions … Off-Label Pharmacologic Agents: Antiepileptic Drugs Topiramate. … Two small RCTs compared drugs with active nonpharmacologic treatments. … No studies compared combined treatments for migraine prevention with drugs alone. … Drugs for preventing migraine headaches in children.

38. S9 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s9.pdf
    October 01, 2007 - detailed (including beneficiary identifiers, contract identifiers pharmacy provider infor- mation on drugs … Key Words: Medicare, Part D, pharmaceuticals (Med Care 2007;45: S9–S12) The Medicare Part D benefit … Part D plan covers 15%, and the beneficiary pays a 5% coinsurance, or copayments of $2 for generic drugs … and $5 for nongeneric drugs. … Drugs provided (including the National Drug Classifica- tion �NDC� code, compound code, and quantity

39. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
    October 01, 2015 - Boston (MA): Vertex Pharmaceuticals, Inc.; 2014 Nov 05 [accessed 2014 Dec 11]. [3 p]. … Boston (MA): Vertex Pharmaceuticals Inc.; 2015 Jan 11 [accessed 2015 May 13]. [5 p]. … Boston (MA): Vertex Pharmaceuticals Inc.; 2015 May 12 [accessed 2015 May 13]. [2 p]. … Boehringer Ingelheim Pharmaceuticals, Inc. … Ridgefield (CT): Boehringer Ingelheim Pharmaceuticals, Inc.; 2014 Oct. 18 p.

40. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
    July 27, 2023 - Center Rapid Response Protocol Project Title: Making Healthcare Safer IV: Protocols for High-Risk Drugs … The “Protocols for High-Risk Drugs: Reducing Adverse Drug Events Related to Anticoagulants” as a patient … High-Alert Drugs: Patient Safety Practices for Intravenous Anticoagulants.